RXDX Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Prometheus Biosciences, Inc. is Fair to ShareholdersBusiness Wire • 04/16/23
Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc.Business Wire • 04/16/23
Prometheus Biosciences to Present at the Oppenheimer 33rd Annual Healthcare ConferenceGlobeNewsWire • 03/09/23
Prometheus Biosciences, Inc. (RXDX) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 02/28/23
Prometheus Biosciences Reports Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Corporate ProgressGlobeNewsWire • 02/28/23
Prometheus Biosciences Announces Two Oral Presentations on PRA023 at the 18th Congress of European Crohn's and Colitis Organisation (ECCO)GlobeNewsWire • 02/22/23
Prometheus Biosciences to Present at the SVB Securities Global Biopharma ConferenceGlobeNewsWire • 02/09/23
Wall Street Analysts Think Prometheus Biosciences, Inc. (RXDX) Could Surge 33.49%: Read This Before Placing a BetZacks Investment Research • 02/02/23
Wall Street Analysts Believe Prometheus Biosciences, Inc. (RXDX) Could Rally 26.51%: Here's is How to TradeZacks Investment Research • 01/10/23
Prometheus Biosciences to Present at the 41st Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/03/23
Why Prometheus Biosciences Stock Is Falling - Prometheus Biosciences (NASDAQ:RXDX)Benzinga • 12/09/22
Prometheus Biosciences, Inc. Announces Pricing of Public Upsized $500 Million Offering of Common StockGlobeNewsWire • 12/09/22
Prometheus Biosciences, Inc. Announces Proposed Public Offering of Common StockGlobeNewsWire • 12/07/22
Prometheus Biosciences soars as new data indicates therapeutic candidate holds promise for bowel diseaseProactive Investors • 12/07/22